What is the requirement for albumin (human albumin) infusion during ascitic paracentesis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Albumin Requirements During Ascitic Paracentesis

Albumin should be administered at a dose of 8g per liter of ascitic fluid removed during large-volume paracentesis (>5L) to prevent post-paracentesis circulatory dysfunction. 1

Rationale for Albumin Administration

Albumin infusion during paracentesis serves to prevent paracentesis-induced circulatory dysfunction (PICD), a serious complication that can lead to:

  • Increased rate of recurrent ascites
  • Development of hepatorenal syndrome
  • Hyponatremia
  • Reduced survival 2

PICD occurs when large volumes of ascitic fluid are removed without adequate plasma volume expansion, leading to hemodynamic disturbances and activation of vasoactive systems.

Evidence-Based Recommendations

Volume-Based Recommendations:

  • Large-volume paracentesis (>5L): Albumin administration at 8g per liter of ascitic fluid removed is strongly recommended 1, 2
  • Paracentesis <5L:
    • Generally, the risk of PICD is low 2
    • However, albumin should still be considered, especially in patients with acute-on-chronic liver failure (ACLF) 1, 3

Supporting Evidence:

A meta-analysis of 17 randomized studies (1,225 patients) demonstrated that albumin infusion:

  • Reduced the odds of PICD by 61% (OR = 0.39,95% CI 0.27–0.55)
  • Reduced hyponatremia by 42% (OR = 0.58,95% CI 0.39–0.87)
  • Reduced mortality by 36% (OR = 0.64,95% CI 0.41–0.98) 2, 4

Albumin has proven superior to alternative plasma expanders (dextran, gelatin, hydroxyethyl starch, hypertonic saline) in preventing PICD 4.

Special Considerations

Acute-on-Chronic Liver Failure (ACLF):

Patients with ACLF require special attention:

  • PICD can develop even with modest-volume paracentesis (<5L) in ACLF patients
  • A randomized study showed that albumin infusion in ACLF patients undergoing <5L paracentesis:
    • Decreased PICD incidence (30% vs 70% without albumin)
    • Reduced complications including hepatic encephalopathy, hyponatremia, and acute kidney injury
    • Lowered in-hospital mortality (27.5% vs 62.5% without albumin) 3

Practical Implementation:

A standardized approach to albumin dosing has been shown to be effective:

  • 25g albumin for 5-6L removed
  • 50g albumin for 7-10L removed
  • 75g albumin for >10L removed 5

This approach resulted in an average albumin dose of 6.5g/L (compared to 8.3g/L in non-standardized dosing) without differences in adverse outcomes 5.

Procedural Considerations

  • Complete drainage to dryness in a single session is recommended
  • Paracentesis should be performed under strict sterile conditions
  • Ultrasound guidance should be used when available
  • Drains should not be left in overnight to reduce infection risk
  • Paracentesis should be limited to less than 8 liters per session to minimize PICD risk 1
  • Diuretics should be reintroduced within 1-2 days after paracentesis 1

Common Pitfalls to Avoid

  1. Underestimating PICD risk in smaller volume paracentesis: While the risk is lower with <5L removal, patients with ACLF still benefit from albumin administration 3

  2. Inadequate monitoring: Patients should be monitored for hypotension during and after paracentesis, as fatal hypotension has been reported in the first 24 hours 1

  3. Repeated low-volume paracentesis: This approach offers no additional benefits and carries a higher risk of procedure-related complications 1

  4. Overlooking the need for albumin in specific populations: Even with smaller volume paracentesis, certain high-risk patients (those with ACLF, poor renal function, or severe liver dysfunction) may benefit from albumin administration 1, 3

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.